Besides the core EMT markers such as E-cad, N-cad, and VIM, we also analysed the expression of other mesenchymal markers, such as TGF-β1 and α-SMA in the above-mentioned ccRCC samples to make the EMT analysis of the above samples stronger. This evidence concerns the gene CDH1 and nonpapillary renal cell carcinoma.